Anand Lokare

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

Annie Young, Andrea Marshall, Jenny Thirlwall et al. · Journal of Clinical Oncology · 2018 · 1.3K citations · Full text

Vte Recurrence, Pathology, Pharmacotherapy +21

Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial

Mark T. Drayson, Stella Bowcock, Tim Planche et al. · The Lancet Oncology · 2019 · 151 citations · Full text

Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma

Martin Kaiser, Andrew Hall, Katrina Walker et al. · Journal of Clinical Oncology · 2023 · 101 citations · Full text

Treatment of cancer‐associated venous thromboembolism: 12‐month outcomes of the placebo versus rivaroxaban randomization of the SELECT‐D Trial (SELECT‐D: 12m)

Andrea Marshall, Mark N. Levine, Catherine St. Hill et al. · Journal of Thrombosis and Haemostasis · 2020 · 78 citations · Full text

Thrombosis, Pulmonary Embolism, Venous Disease +14

OC-11 - Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism

Annie Young, Jane Phillips, Helen Hancocks et al. · Thrombosis Research · 2016 · 36 citations

Thrombosis, Venous Thrombosis, Selected Cancer Patients +12